Patient Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Illumina
ILMN
|
+$18.3M |
| 2 |
EVRI
Everi Holdings
EVRI
|
+$11.9M |
| 3 |
CVS Health
CVS
|
+$10.5M |
| 4 |
Biogen
BIIB
|
+$8.56M |
| 5 |
PPLI
People Inc
PPLI
|
+$8.07M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Capital One
COF
|
+$37.6M |
| 2 |
Uber
UBER
|
+$31.1M |
| 3 |
Delta Air Lines
DAL
|
+$28.6M |
| 4 |
OneMain Financial
OMF
|
+$15.2M |
| 5 |
JPMorgan Chase
JPM
|
+$11.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 32.63% |
| 2 | Financials | 19.21% |
| 3 | Communication Services | 14.07% |
| 4 | Healthcare | 11.39% |
| 5 | Energy | 10.84% |
Similar funds
Patient Capital Management's Q2 2024 Portfolio in Review
As of Q2 2024, Patient Capital Management held 44 positions worth $1.88B, down 8.4% from $2.05B the previous quarter. Its ten largest holdings account for 48% of the portfolio.
Patient Capital Management withdrew a net $138M in Q2 2024, closing 4 positions and reducing 25 holdings. Its most notable exit was Capital One, an estimated $37.6M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 33% of assets, up from 31% a quarter earlier, followed by Financials and Communication Services.
Against the trend, Patient Capital Management opened a new position in Everi Holdings worth $12.3M.
- Patient Capital Management's largest Q2 2024 buy was Everi Holdings: 1,463,253 shares worth $12.3M.
- Patient Capital Management added most to Illumina in Q2 2024, an estimated $18.3M increase.
- Patient Capital Management's biggest Q2 2024 reduction was Uber, cutting an estimated $31.1M.
- Patient Capital Management fully exited Capital One in Q2 2024, selling an estimated $37.6M.
- Patient Capital Management's ten largest holdings make up 48% of its $1.88B portfolio in Q2 2024.
- Patient Capital Management opened 2 new positions and closed 4 in Q2 2024.
- Patient Capital Management's portfolio value fell 8.4% quarter-over-quarter to $1.88B.
Based on Patient Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.